Covid Drugmaker Vir Biotechnology Replaces CEO Scangos With Bayer’s De Backer


Vir Biotechnology Inc. is changing Chief Government Officer George Scangos with Bayer AG government Marianne De Backer because the infectious illness firm seeks a follow-up to its Covid-19 antibody. 

Scangos, 74,  who has led the corporate since its inception in 2017, is retiring after an extended profession within the business. He was CEO of Biogen Inc. earlier than taking the highest job at Vir the place he shepherded the corporate by means of the introduction of its solely accredited drugs, sotrovimab, the Covid antibody developed with GSK Plc.


Please enter your comment!
Please enter your name here